HU893412D0 - Inhibitors of interleucin-1 - Google Patents

Inhibitors of interleucin-1

Info

Publication number
HU893412D0
HU893412D0 HU893412A HU341289A HU893412D0 HU 893412 D0 HU893412 D0 HU 893412D0 HU 893412 A HU893412 A HU 893412A HU 341289 A HU341289 A HU 341289A HU 893412 D0 HU893412 D0 HU 893412D0
Authority
HU
Hungary
Prior art keywords
interleucin
inhibitors
Prior art date
Application number
HU893412A
Other languages
Hungarian (hu)
Other versions
HU215434B (en
Inventor
Charles H Hannum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Priority to HU9803037A priority Critical patent/HU9803037D0/en
Publication of HU893412D0 publication Critical patent/HU893412D0/en
Publication of HU215434B publication Critical patent/HU215434B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
HU3412/89A 1988-05-27 1989-05-25 Process for producing interleukin-1inhibitors, dna sequences encoding them, and vectors and host cells HU215434B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9803037A HU9803037D0 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03

Publications (2)

Publication Number Publication Date
HU893412D0 true HU893412D0 (en) 1991-05-28
HU215434B HU215434B (en) 1999-04-28

Family

ID=27394086

Family Applications (3)

Application Number Title Priority Date Filing Date
HU9803037A HU9803037D0 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors
HU9803037A HU222810B1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors
HU3412/89A HU215434B (en) 1988-05-27 1989-05-25 Process for producing interleukin-1inhibitors, dna sequences encoding them, and vectors and host cells

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HU9803037A HU9803037D0 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors
HU9803037A HU222810B1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Country Status (9)

Country Link
JP (2) JP3192651B2 (en)
KR (1) KR970002917B1 (en)
BR (1) BR8907457A (en)
DK (1) DK172763B1 (en)
FI (2) FI109206B (en)
HU (3) HU9803037D0 (en)
NO (2) NO316122B1 (en)
OA (1) OA09631A (en)
WO (1) WO1989011540A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
DE69131044T2 (en) * 1990-05-01 1999-11-18 Chiron Corp INTERLEUKIN-I ANTAGONIST AND ITS USE
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5840496A (en) * 1990-10-09 1998-11-24 Chiron Corporation Method for diagnosing endometrial cancer
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP1442132A2 (en) * 2001-10-26 2004-08-04 Novartis AG Methods for the treatment of osteoarthritis and compositions thereof
MXPA04009681A (en) 2002-04-05 2005-01-11 Amgen Inc Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors.
US7709611B2 (en) 2004-08-04 2010-05-04 Amgen Inc. Antibodies to Dkk-1
NO2188313T3 (en) 2007-08-21 2018-03-31
JP5976319B2 (en) * 2008-09-12 2016-08-23 エックスバイオテク，インコーポレイテッドＸｂｉｏｔｅｃｈ，Ｉｎｃ． Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
ES2600616T3 (en) 2011-03-14 2017-02-10 Phlogo Aps Interleukin-1 receptor antagonists
AU2012242666A1 (en) 2011-04-15 2013-11-28 Merck Patent Gmbh Anti- IL-1R1 inhibitors for use in cancer
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
TWI742054B (en) 2016-03-08 2021-10-11 美商健生生物科技公司 Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855747T2 (en) * 1987-08-26 1997-06-12 Biogen Inc BIOLOGICAL MATERIALS, THEIR PRODUCTION AND USE IN THERAPY

Also Published As

Publication number Publication date
FI20020545A (en) 2002-03-21
BR8907457A (en) 1991-04-02
NO316917B1 (en) 2004-06-21
DK172763B1 (en) 1999-07-05
DK8591D0 (en) 1991-01-18
HU215434B (en) 1999-04-28
NO905090L (en) 1991-01-28
WO1989011540A1 (en) 1989-11-30
AU633831B2 (en) 1993-02-11
NO316122B1 (en) 2003-12-15
HU222810B1 (en) 2003-11-28
JP2001029093A (en) 2001-02-06
JPH03505279A (en) 1991-11-21
DK8591A (en) 1991-01-18
NO905090D0 (en) 1990-11-23
FI109206B (en) 2002-06-14
NO20014783D0 (en) 2001-10-01
HU9803037D0 (en) 1999-11-29
AU3746989A (en) 1989-12-12
KR970002917B1 (en) 1997-03-12
OA09631A (en) 1993-04-30
NO20014783L (en) 1991-01-28
JP3192651B2 (en) 2001-07-30
FI905812A0 (en) 1990-11-26

Similar Documents

Publication Publication Date Title
ZA894068B (en) Novel alpha-glucosidase inhibitors
HU893412D0 (en) Inhibitors of interleucin-1
JPS6447799A (en) Tissue factor inhibitor
GB2333292B (en) Derivatives of hexaazoisowurtzitane
GR862032B (en) Dopamine-b-hydroxylase inhibitors
ZW21586A1 (en) Dopamine-b-hydroxylase inhibitors
ZA899924B (en) Renin inhibitors
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
GB8802421D0 (en) Set of parts
EP0411395A3 (en) Use of ace inhibitors for atherosclerosis-prophylaxis
GR860362B (en) Dopamine -b-hydroxylase inhibitors
ZA904825B (en) Inhibition of potato-sprouting
BG46662A1 (en) Inhibitor of urease
IE862859L (en) INHIBITORS OF DOPAMINE-ß-HYDROXYLASE
IE872276L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
YU11688A (en) Derivatives of pyridazodiazepine
IE881760L (en) Derivatives of n-phenylpyrazoles
CS521788A1 (en) Derivatives of trimethoprine
CA60659S (en) Set of jewellery
CS862387A1 (en) Smesny inhibitor koroze oceli
CS25787A1 (en) Inhibitor koroze
CS870188A1 (en) Method of 4-amino-1-phenyl-chloro-6-pyridazone
IE882090L (en) New use of 5-ht3-antagonists
IE862056L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: AMGEN INC., US